BioCentury
ARTICLE | Financial News

BG proposes follow-on

January 25, 2013 1:57 AM UTC

Diagnostics company BG Medicine Inc. (NASDAQ:BGMD) said it is planning a follow-on underwritten by Lazard. BG also said that Aspire Capital Fund agreed to purchase up to $12 million in BG Medicine stock over the next two years. Aspire received 132,743 shares up front, valued at $329,202 based on BG Medicine's close of $2.48 on Thursday. BG Medicine, which made both announcements after market close on Thursday, was up $0.18 to $2.48. ...